Antimicrobial resistance (AMR) is a serious threat to global public health, with approximately
5 million deaths associated with bacterial AMR in 2019. Tackling AMR requires a …

Phage therapy, the use of bacteriophages (phages) to treat bacterial infections, is regaining
momentum as a promising weapon against the rising threat of multidrug-resistant (MDR) …

Using phages as salvage therapy for nonhealing infections is gaining recognition as a
viable solution for patients with such infections. The escalating issue of antibiotic resistance …

The increase in the incidence of antibiotic-resistant bacteria poses a global public health
threat. According to a 2019 WHO report, approximately 1.27 million deaths were attributed to …

Bacteriophages (phages), viruses capable of infecting and lysing bacteria, are a promising
alternative for treating infections from hypervirulent, antibiotic-resistant pathogens like …

New approaches to managing infections in cardiac and peripheral vascular surgery are
required to reduce costs to patients and healthcare providers. Bacteriophage (phage) …

Background Persistent and resistant infections caused by bacteria are increasing in
numbers and pose a treatment challenge to the medical community and public health …

Antibiotic failure is one of the most worrisome threats to global health. Among the new
therapeutic efforts that are being explored, the use of bacteriophages (viruses that kill …

Phage therapy is a highly promising approach to address the challenge that is presented by
the global burden of antimicrobial resistance. Given the natural specificity of phages, phage …

Viruses that infect as well as often kill bacteria are called bacteriophages, or phages.
Because of their ability to act bactericidally, phages increasingly are being employed …